Zeev Dvashi and the Plas-Free team recently secured CE Mark for their ClearPlasma device - an innovative technology that removes fibrinolytic factors from blood products, strengthening clot formation and improving bleeding control. 🩸
In this episode, Zeev looks beyond the technical milestones and shares the real strategic challenges behind MedTech success. He speaks candidly about navigating regulatory hurdles on the path to CE Mark, the true cost and complexity of commercialisation, and what it takes to lead a company through high-stakes inflection points.
